Therapeutic Commercialization
RoosterBio, USA
RoosterBio, is an expert in radically simplifying the use of adult human mesenchymal stem/stromal cells (hMSCs) and extracellular vesicles (EVs) to propel the commercialization of therapeutic technologies. By enabling living cells to become more affordable at the lowest cost per million cells with industry-leading quality, we make them easier to access and much simpler to incorporate into product development efforts, leading to the rapid acceleration of products coming to market that incorporate these technologies.
Global Presence
Supports 500+ government, academia, institution, and industry partners from more than 25 countries across 6 continents.
Regulatory Expertise
Our cGMP media and cells, supported by Type II FDA Master Files, are being used as ancillary and raw starting materials for multiple ongoing and planned registered clinical trials.
.png)
.png)
.png)
.png)